IP Library › Patent Application 13228887
Patent Application
App. No. 13/228,887

Devices and Methods for Tissue Engineering

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/228,887
Abstract

A tissue scaffold fabricated from tantalum fiber forms a rigid three-dimensional porous matrix having a tantalum composition. Porosity in the form of interconnected pore space is provided by the space between the tantalum fiber in the porous matrix. Strength of the porous matrix is provided by tantalum fiber fused and bonded into the rigid three-dimensional matrix having a specific pore size and pore size distribution. The tissue scaffold supports tissue in-growth to provide osteoconductivity as a tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims (30)

1 . A porous tissue scaffold comprising:

tantalum fibers bonded together to provide a rigid three-dimensional matrix;

interconnected pore space in the rigid three-dimensional matrix, the interconnected pore space having a pore size distribution predetermined by volatile components present before the tantalum fibers are bonded together; and

the rigid three-dimensional matrix forming a porous tissue scaffold having a tantalum composition.

2 . The porous tissue scaffold according to claim 1 wherein the tantalum fibers bonded together comprise sintered fibers.

3 . The porous tissue scaffold according to claim 1 wherein the pore size distribution has a mode between about 50 microns and 600 microns.

4 . The porous tissue scaffold according to claim 1 wherein the pore size distribution has a bi-modal size distribution.

5 . The porous tissue scaffold according to claim 1 wherein the tantalum fibers have a diameter ranging from about 3 microns to about 500 microns.

6 . The porous tissue scaffold according to claim 5 wherein the tantalum fibers have a diameter ranging from about 25 microns to about 200 microns.

7 . The porous tissue scaffold according to claim 1 wherein the tantalum fibers have a length of about 3 to about 1000 times the diameter.

8 . The porous tissue scaffold according to claim 1 wherein the tantalum fibers have a length of about 20 to 50 times the diameter.

9 . A porous tissue scaffold comprising:

fibers in an intertangled relationship, the fibers having a tantalum composition;

a tantalum material forming bonds between overlapping and adjacent fibers;

the fibers and tantalum material providing a rigid three-dimensional matrix;

interconnected pore space in the rigid three-dimensional matrix, the interconnected pore space having a pore size distribution predetermined by volatile components; and

the rigid three-dimensional matrix forming a porous tissue scaffold.

10 . The porous tissue scaffold according to claim 9 wherein the pore size distribution has a mode between about 100 microns and 500 microns.

11 . The porous tissue scaffold according to claim 9 wherein the pore size distribution has a bi-modal size distribution.

12 . The porous tissue scaffold according to claim 9 wherein the fibers have a diameter ranging from about 2 microns to about 500 microns.

13 . The porous tissue scaffold according to claim 12 wherein the fibers have a diameter ranging from about 25 microns to about 200 microns.

14 . The porous tissue scaffold according to claim 9 further comprising a functional material on the surface of the three dimensional matrix.

15 . A method of forming a porous tissue scaffold comprising:

mixing tantalum fiber with binder, a pore former, and a liquid to provide a homogeneous mixture;

forming the homogeneous mixture into a shaped object;

curing the shaped object into the tissue scaffold; and

applying a functional material to the tissue scaffold.

16 . The method according to claim 15 wherein the step of applying a functional material comprises adding the functional material to the homogeneous mixture during the mixing step.

17 . The method according to claim 15 wherein the step of applying a functional material comprises adding the functional material to the tissue scaffold during the curing step.

18 . The method according to claim 15 wherein the step of applying a functional material comprises at least one of an immersion process, a chemical vapor deposition process and a cathodic arc deposition process.

Assignments (3)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2011
From: LIU, JAMES J.
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 026901/0804 →